Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery
May 12 (Reuters) - Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion in its latest funding round led by existing investor Thrive Capital.